[1]中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324~329.
|
[2]GUO Y, GUO H, ZHANG L, et al.Genomic analysis of anti-hep-atitis B virus (HBV) activity by small instble HBV-producingcells[J].J Virol, 2005, 79 (220∶14392-14403.
|
[3]BENHAMOUY.Treatment algorithm for chronic hepatitis B in HIV-infected patients[J].J Hepatol, 2006, 44 (1 Suppl) ∶S90-S94.
|
[4]Wolters LM, Niesters HG, de Man RA, et al.Nucleoside analoguesfor chronic hepatitis B[J].Eur J Gastroenterol Hepatol, 2001, 13 (12) ∶1499-1506.
|
[5]蒋晔, 徐智儒, 张晓青.抗乙肝新药阿德福韦酯的研究进展[J].中国新药与临床杂志, 2004, 23 (6) ∶373-377.
|
[6]Hadziyannis SJ, Tassopoulos NS, Heathcote EJ, et al.Adefovir dip-ivoxil for the treatment of hepatitis B e antigen-negative chronichepatitis B[J].N Engl J Med, 2003, 348∶800-807.
|
[7]Marcellin P, Chang TT, Lim SG, et al.Adefovir dipivoxil for hetreatment of hepatitis B e antigen-positive chronic hepatitis B[J].NEngl J Med, 2003, 348∶808-816.
|
[8]Hadziyannis S, Tassopoulos N, Chang TT, et al.three-year studyof adefovir dipivoxil (ADV) demonstrates sustained efficacy in pre-sumed precore mutant chronic hepatitis B patients in a long-termsafety and efficacy study[J].J Hepatol, 2004 (Suppl 1) ∶17 (Ab-stract 46) .
|
[9]Zoulim F.Assessment of treatment efficacy in HBVinfection and dis-ease[J].J Hepatol, 2006, 44 (1 Suppl) ∶S95~99.
|
[10]于建国, 倪介萍, 郭葆玉.慢性乙型肝炎抗病毒药物临床应用现状[J].临床军医杂志, 2002, 30 (6) ∶80~82.
|
[1] | Shengdeng CHEN, Zhiqiang MOU, Zhongyao CHEN, Jian WEN, Qiu LI. Predictive value of preoperative alkaline phosphatase to prealbumin ratio in prognosis and postoperative complications in patients with hepatocellular carcinoma after radical tumor resection[J]. Journal of Clinical Hepatology, 2023, 39(1): 118-127. doi: 10.3969/j.issn.1001-5256.2023.01.018 |
[2] | Branch of Hepatobiliary Diseases, Chinese Association of Chinese Medicine. The standards of traditional Chinese medicine syndrome differentiation for viral hepatitis[J]. Journal of Clinical Hepatology, 2017, 33(10): 1839-1846. doi: 10.3969/j.issn.1001-5256.2017.10.002 |
[3] | Zhang Yi, Yu YongSheng, Tang ZhengHao, Jiang Hong, Xi Min, Zang GuoQing. Detection of serum retinol-binding protein, pre-albumin and albumin in patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2009, 25(6): 422-424. |
[4] | Jin XueYuan, Lou Min, Zhao Ping, Long SuYun. Clinical significance of the serum neopterin detection in patients with chronic viral hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 90-91. |
[7] | Luo KaiZhong, Su XianShi, Jiang YongFang. Measurement of serum level of insulin-like growth factor binding protein-3 in patients with viral hepatitis and its assessment on liver function[J]. Journal of Clinical Hepatology, 2006, 22(1): 24-26. |
[8] | Tao Hu, Gao Tao, Xu Bin. Revaluate the clinical significance of serum transferrin changes in patients with hepatitis[J]. Journal of Clinical Hepatology, 2004, 20(3): 148-149. |
[10] | Li ManNi, Zhang Fang, Su XianShi. Cloning of prealbumin cDNA and construction of the stable transfective cell line[J]. Journal of Clinical Hepatology, 2002, 18(4): 232-234. |
[11] | Zhang Fang, Ceng XiaoBo, Su XianShi, Li ManNi. Significance of Assaying Serum Prealbumin in the patients with viral Hepatitis B[J]. Journal of Clinical Hepatology, 2001, 17(3): 163-164. |
[12] | He DongGou, Chen BoMing, Lin YongPing. Research of T lymphocyte subtypes and the phagocytosis activity of macrophages in the patients with virul hepatitis[J]. Journal of Clinical Hepatology, 2000, 16(1): 30-31. |
[13] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |